Search

everythinglearnresearchcommunity

for

Search:↓

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

PPX causes much less hair loss than traditional taxanes.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

A new method accurately measures cell changes in breast cancer.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Targeting lipid metabolism can help treat advanced, resistant cancers.